imet 3146 has been researched along with Experimental Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gutsche, W; Güttner, J; Jungstand, W; Krebs, D; Ozegowski, W; Röppnack, G; Wohlrabe, K; Zchiesche, W | 1 |
1 other study(ies) available for imet 3146 and Experimental Neoplasms
Article | Year |
---|---|
Beta-[1-Phenyl-5-bis(beta-chloroethyl)-amino-benzimidazolyl-(2)]-DL-alanine (ZIMET 3164): an immunosuppressant without marked anti-cancer effect.
Topics: Animals; Antibody Formation; Antineoplastic Agents; Benzimidazoles; Chlorambucil; Cyclophosphamide; Immunosuppressive Agents; Lethal Dose 50; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Nitrogen Mustard Compounds; Rats | 1979 |